Naturmega to Introduce SUPRIAX2™ and Showcase Next-Generation Lipid Innovation at SupplySide Global 2026 Naturmega, an advanced lipid science company focused on omega-3 and next-generation lipid technologies, is preparing to introduce SUPRIAX2™ to the North American market at SupplySide Global 2026…
Agenus Reports Updated NEST Phase 2 Results Supporting Neoadjuvant BOT+BAL in Colon Cancer Agenus Inc. (Nasdaq: AGEN), a biotechnology company focused on immuno-oncology innovation, has announced the peer-reviewed publication of updated results from the investigator-sponsored Phase 2 NEST clinical trial…
Axoft Introduces Fleuron WISE Elastomer to Enable High-Resolution Imaging in Aqueous Environments Axoft, a neurotechnology company developing advanced materials and technologies for applications at the intersection of biology and electronics, has announced the introduction of Fleuron® Water Invisible Soft Elastomer…
GeneDx Study Shows Hospital-Wide Rapid Genome Sequencing Can Improve Pediatric Diagnosis, Outcomes and Health System Efficiency GeneDx (Nasdaq: WGS), a company focused on rare disease diagnosis and the use of genomic information to improve health outcomes, has announced new findings…
European Commission Broadens Trodelvy’s First-Line Use in Metastatic Triple-Negative Breast Cancer Regardless of PD-L1 Status Gilead Sciences, Inc.announced that the European Commission (EC) has granted marketing authorization for Trodelvy® (sacituzumab govitecan-hziy) in combination with Keytruda® (pembrolizumab) for the first-line treatment…
Genentech to Invest $750 Million in New Device Fill-Finish Manufacturing Facility in Oregon Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), has announced plans to invest approximately $750 million to establish a new device fill-finish manufacturing…
Regenerative Research Foundation Selected as a Winner of NIH’s Complement-ARIE Challenge The Regenerative Research Foundation has announced that its Neural Stem Cell Institute (NSCI) has been selected as a Phase 1 winner in the National Institutes of Health’s (NIH) Complement-ARIE…
Life Couriers Completes Acquisition by JLL Partners and Appoints Edward DeMartini as CEO to Drive Global Healthcare Logistics Growth Life Couriers, a global provider of time-critical healthcare logistics and transportation solutions, has completed its acquisition by JLL Partners, a New…
Natera Collaborates With Kupando Therapeutics to Monitor Molecular Response in Phase 1 Trial of Novel Immunotherapy KUP-101 Natera, Inc., a global leader in cell-free DNA analysis and precision medicine, has announced a new collaboration with Kupando Therapeutics to support a…
Integrated DNA Technologies Study Establishes New Benchmark for CRISPR Off-Target Detection and Analysis Integrated DNA Technologies (IDT), a Danaher company and a global provider of genomics solutions, has announced the publication of a new peer-reviewed study in Nature Communications that…
Bruker Expands Drug Discovery Capabilities with Majority Investment in MIMETAS and Organ-on-a-Chip Technology Bruker Corporation has announced a majority investment in MIMETAS B.V., a biotechnology company specializing in organ-on-a-chip platforms and advanced human tissue and disease models for pharmaceutical research…
AIDS Healthcare Foundation Supports Bipartisan SUSTAIN 340B Act to Strengthen and Protect Federal Drug Discount Program AIDS Healthcare Foundation (AHF) has welcomed the introduction of draft bipartisan legislation in the U.S. Senate aimed at addressing ongoing challenges facing the federal…